Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Trial of CRD007 in Adult Subjects with Asthma
2015-002656-26Phase 2Completed
- Sponsor
- RSPR Pharma
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing CRD007 arm with Placebo arm (2 arms). Primary endpoint: Average dose of inhaled corticosteroids. Started Sep 2015; status: completed.
02
Drugs
pemirolast
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-002656-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002656-26.